Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysanthi Staveri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|March 22, 2021
What's New in the Treatment of Systemic Lupus ErythematosusStamatis Nick Liossis, Chrysanthi Staveri
Frontiers in Medicine|July 21, 2022
The Role of B Cells in Scleroderma Lung Disease PathogenesisStamatis-Nick C Liossis, Chrysanthi Staveri
Current Rheumatology Reports|November 5, 2017
B Cell-Based Treatments in SLE: Past Experience and Current DirectionsStamatis-Nick C Liossis, Chrysanthi Staveri
Seminars in Arthritis and Rheumatism|October 30, 2016
New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumabChrysanthi Staveri, Dimitrios Karokis, Stamatis-Nick C Liossis
Rheumatology International|April 28, 2025
Favorable outcomes for patients with refractory systemic lupus erythematosus treated with rituximab as evidenced with a follow-up of ≥ 10 years: a real-world evidence studyChrysanthi Staveri, Chrysa Lykoura, Konstantinos Melissaropoulos, et al.
Journal of Clinical Medicine|July 29, 2025
Combining Laboratory and Imaging Evaluation for Cardiovascular Risk Stratification in Systemic Lupus ErythematosusChrysanthi Staveri, Vassiliki Vartela, Sophie I Mavrogeni, et al.
Rheumatology International|July 4, 2026
Myocarditis as the first sign of SLE: a case report and review of the literatureChrysanthi Staveri, Sophie I Mavrogeni, Alexandros Alexopoulos, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|March 22, 2021
What's New in the Treatment of Systemic Lupus ErythematosusStamatis Nick Liossis, Chrysanthi Staveri
Frontiers in Medicine|July 21, 2022
The Role of B Cells in Scleroderma Lung Disease PathogenesisStamatis-Nick C Liossis, Chrysanthi Staveri
Current Rheumatology Reports|November 5, 2017
B Cell-Based Treatments in SLE: Past Experience and Current DirectionsStamatis-Nick C Liossis, Chrysanthi Staveri
Seminars in Arthritis and Rheumatism|October 30, 2016
New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumabChrysanthi Staveri, Dimitrios Karokis, Stamatis-Nick C Liossis
Rheumatology International|April 28, 2025
Favorable outcomes for patients with refractory systemic lupus erythematosus treated with rituximab as evidenced with a follow-up of ≥ 10 years: a real-world evidence studyChrysanthi Staveri, Chrysa Lykoura, Konstantinos Melissaropoulos, et al.
Journal of Clinical Medicine|July 29, 2025
Combining Laboratory and Imaging Evaluation for Cardiovascular Risk Stratification in Systemic Lupus ErythematosusChrysanthi Staveri, Vassiliki Vartela, Sophie I Mavrogeni, et al.
Rheumatology International|July 4, 2026
Myocarditis as the first sign of SLE: a case report and review of the literatureChrysanthi Staveri, Sophie I Mavrogeni, Alexandros Alexopoulos, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Pageof 1